We recently met with 170 companies as part of a research road trip that crossed the US and Europe, to test existing investment theses, and look for new opportunities and trends. One key takeaway was that we have found far more attractive opportunities in global small to midcap (SMID) companies.... Show More
Sentiment in the life sciences sector remains weak. However as always companies with near-term catalysts, or milestones, are attracting attention, and I'll mention four names that I think are worth having a closer look at. Show More
Navigating the almost 2000 stocks in the microcap universe can be daunting for investors, particularly as broker coverage is so thin. But this is precisely what attracts us. We use our large research team and disciplined process to uncover great value stocks whose growth prospects are being ignored by the... Show More
Pacific Energy (PEA) announced an additional 11 Megawatts of power generation capacity for their Western Australian Pilgangoora lithium project this week. The award takes year-on-year growth to 8.0%, with a good chance of further contract awards in the near term. PEA’s take-or-pay contract structure offers defensive earnings, a positive growth... Show More
When looking for relatively low-risk equity investments, companies with strong balance sheets are a good place to start the search. If they happen to be effectively debt-free with a net cash position, then even better. With no financial pressure on companies to service loans during business downturns, the risk of... Show More
If interest rates continue to rise, it would indicate a loosening of monetary policy and a pro-growth, high-spending political and economic environment. Initially, and understandably, the bond-proxy and income stocks have sold-off markedly: property trusts, infrastructure and, in Australia, the major banks and telcos. Liquidated funds would quite rightly be... Show More